Correction: The inflammatory marker SIRI acts as a statistical mediator between ApoB/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Correction: The inflammatory marker SIRI serves as a statistical mediator linking the ApoB/ApoA1 ratio to atrial fibrillation, with combined biomarkers demonstrating superior discriminative power for atrial fibrillation compared to individual markers.
Clinical Scorecard: Correction: The inflammatory marker SIRI serves as a statistical mediator linking the ApoB/ApoA1 ratio to atrial fibrillation, with combined biomarkers demonstrating superior discriminative power for atrial fibrillation compared to individual markers.
At a Glance
Category
Detail
Condition
Atrial Fibrillation
Key Mechanisms
SIRI as a mediator between ApoB/ApoA1 ratio and atrial fibrillation.
Target Population
Patients at risk for atrial fibrillation.
Care Setting
Cardiovascular medicine
Key Highlights
SIRI acts as a statistical mediator in atrial fibrillation.
Combined biomarkers outperform individual markers in discriminative ability.
Correction issued for data availability statement.
